D-0436-2022 Class II Terminated

Recalled by Edge Pharma, LLC — Colchester, VT

FDA drug recall D-0436-2022 was initiated by Edge Pharma, LLC on Dec 6, 2021 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Jun 7, 2023). Affected quantity: 74 jars.

Recall details

Product Type
Drugs
Report Date
Feb 2, 2022
Initiation Date
Dec 6, 2021
Termination Date
Jun 7, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
74 jars

Product description

LT Topical Cream, Lidocaine/Tetracaine, 23%/7%, 60gm per jar, Multiple Dose Container for Topical Use, Edge Pharma, LLC, 856 Hercules, VT, Colchester, VT 05446, NDC 05446-1647-01

Reason for recall

CGMP Deviations

Distribution pattern

nationwide

Code information

08-2021-23@9 02-19-2022, 09-2021-07@13 03-06-2022 & 10-2021-22@5 04-20-2022.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0436-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0436-2022. Report a data issue: hello@regdatalab.com.